Berberine and Metabolic Health: What Trials Show
Share
Berberine is a bright yellow plant compound with a long résumé in traditional Asian medicine and a surprisingly modern research profile. It comes from plants such as barberry, goldenthread, Coptis root, and Phellodendron bark [1][2], and in 2004 a paper in Nature Medicine showed it lowered cholesterol through a mechanism different from statins [3]. Two decades later, berberine is again at the center of supplement research. NutraIngredients' October 9, 2026, roundup of metabolic health science featured two new berberine trials, including a small study measuring GLP-1, the gut hormone behind today's weight-loss drugs [4].
Key Takeaways
- In a meta-analysis of 18 placebo-controlled trials (1,788 adults), berberine produced small reductions in LDL cholesterol, total cholesterol, and triglycerides [1].
- A meta-analysis of 27 randomized trials (2,569 patients) found berberine lowered blood sugar markers more than lifestyle changes alone [2].
- Average weight change is modest: about 0.88 kg (roughly 2 lb) more than control in a 2026 meta-analysis [5].
- Digestive side effects are the most common complaint [1][6].
- Berberine can change how the body processes some medications and should be avoided during pregnancy and breastfeeding [7][8].
What Is Berberine?
Berberine is an alkaloid, a nitrogen-containing plant compound. It is frequently used in China alongside conventional care for blood sugar, blood lipids, and blood pressure [2], and it is now widely sold as a purified supplement [1].
The 2004 discovery gave berberine its scientific credibility. Researchers found that it increases LDL receptors on liver cells, the "docking stations" that pull LDL cholesterol out of the bloodstream. Its route differs from that of statins: berberine stabilizes the receptor's genetic message (mRNA), so cells make more receptors [3]. In that study, 32 people with high cholesterol who took berberine for 3 months saw total cholesterol fall by 29%, triglycerides by 35%, and LDL cholesterol by 25%. In hamsters, berberine raised liver LDL receptor protein 2.6-fold, an animal finding that helped explain the human results [3].
Benefits: What the Research Shows
Blood sugar
A 2008 pilot study compared berberine with metformin, a widely used diabetes medicine, at 0.5 g three times a day for 3 months in 36 adults with newly diagnosed type 2 diabetes. The two lowered blood sugar to a similar degree; in the berberine group, HbA1c fell from 9.5% to 7.5% [6]. In a second part of the study, 48 adults whose diabetes was poorly controlled added berberine for 3 months. HbA1c dropped from 8.1% to 7.3%, fasting insulin fell 28.1%, and a measure of insulin resistance fell 44.7%. No liver or kidney problems were found [6].
The larger picture comes from a 2015 meta-analysis of 27 randomized trials and 2,569 patients. Berberine plus lifestyle changes lowered fasting glucose, after-meal glucose, and HbA1c more than lifestyle changes or placebo alone. Adding berberine to diabetes medicines improved results compared with the medicines alone, and no serious adverse reactions were reported [2]. Most of these trials were conducted in China and involved people with diabetes, not healthy adults.
Cholesterol and triglycerides
In the 2015 meta-analysis, berberine combined with lipid-lowering drugs reduced total and LDL cholesterol more than the drugs alone. When berberine was compared head to head with lipid drugs, LDL reductions were similar, and berberine did better on triglycerides and HDL [2]. Blood pressure also tended to fall more when berberine was added to lifestyle changes or blood pressure medicines [2].
The strongest evidence is for blood lipids. A 2023 meta-analysis limited to placebo-controlled trials pooled 18 studies and 1,788 adults treated for 4 to 24 weeks [1]. Berberine lowered:
- LDL cholesterol by 0.46 mmol/L (about 18 mg/dL)
- Total cholesterol by 0.48 mmol/L (about 19 mg/dL)
- Triglycerides by 0.34 mmol/L (about 30 mg/dL)
HDL cholesterol rose slightly in women but not in men, an unexpected sex difference the authors say needs study. They describe the overall effects as small and call for large trials measuring clinical outcomes [1].
Weight and waist size
A 2026 meta-analysis of 23 randomized trials found berberine reduced body weight by 0.88 kg, BMI by 0.48, and waist circumference by 1.32 cm more than control, with no change in waist-to-hip ratio [5]. That is a modest effect. The authors noted that many trials reported purity and dose poorly and lacked rigorous blinding [5].
The GLP-1 question
Berberine's newest headline is GLP-1. In a placebo-controlled study of 26 healthy adults at metabolic risk, a 200 mg daily dose of a branded "bio-optimized" berberine increased fasting and after-meal GLP-1 levels [4]. The study was small and run by the ingredient's maker. A separate 12-week trial of 93 adults with obesity found that a combination of 1,000 mg berberine, white mulberry leaf extract, and chromium improved BMI, body fat, and insulin sensitivity, but it could not separate the effect of each ingredient [4].
These findings are early. Berberine is not a GLP-1 medication and should not be used in place of one.
Why the evidence has limits
Most berberine research comes from one region: 15 of the 18 trials in the 2023 lipid meta-analysis were conducted in mainland China and Hong Kong [1]. Weight trials often reported product purity and dose poorly, and many lacked strong blinding or randomization [5]. Results may not translate directly to every population or product.
Side Effects and Safety
- Digestive effects. In the metformin comparison study, 34.5% of participants had temporary digestive side effects [6]. In placebo-controlled trials, digestive complaints ranged from 2% to 23% with berberine versus 2% to 15% with placebo [1].
- Drug interactions. After 2 weeks of 300 mg three times a day, berberine reduced the activity of three liver enzymes (CYP2D6, CYP2C9, and CYP3A4) that process many common medicines [7].
- Pregnancy and infants. The berberine in goldenseal can be harmful to newborns; NCCIH advises that goldenseal not be used during pregnancy or breastfeeding or given to infants [8].
- Diabetes medicines. Because berberine lowers blood sugar [2][6], combining it with glucose-lowering drugs needs medical supervision. Goldenseal extract lowered metformin levels by about 25% in one NCCIH-funded study [8].
How Berberine Is Typically Taken
The human studies described here used divided daily doses, such as 0.5 g three times a day for 3 months [6] or 300 mg three times a day for 2 weeks [7]. Newer branded forms have been tested at 200 mg a day [4]. No official intake recommendation exists, so follow the label and your healthcare professional's advice.
What Researchers Are Still Asking
- Do the lipid changes lower heart risk? Trials so far measure blood markers, not heart events [1].
- Why do women and men respond differently? HDL effects differed by sex in pooled data [1].
- Do newer low-dose forms work? The GLP-1 findings come from one small, company-run study [4].
- How pure are products? Better reporting of purity and dose is needed in trials [5].
Choosing a Berberine Supplement
- Check the amount per capsule against studied doses, and count total daily intake.
- Look for third-party testing, since dietary supplements are not approved by the FDA before they are sold [8].
- Review your medications with a pharmacist or prescriber first [7].
Frequently Asked Questions
Is berberine "nature's GLP-1"?
No. One small study found a branded berberine raised GLP-1 levels [4], but berberine is not a GLP-1 medication, and its average effect on weight is modest [5].
How long does berberine take to work?
Blood sugar changes appeared within 1 week in one study [6]; lipid trials lasted 4 to 24 weeks [1].
Can I take berberine with metformin?
Only with your prescriber's guidance. Both lower blood sugar [6], and berberine-containing goldenseal changed metformin levels in one study [8].
Who should avoid berberine?
People who are pregnant or breastfeeding, infants, and anyone taking medicines processed by CYP enzymes without medical advice [7][8].
The Bottom Line
Berberine has one of the more substantial evidence bases among metabolic botanicals, with meta-analyses showing small improvements in cholesterol, triglycerides, and blood sugar markers and a modest effect on weight [1][2][5]. The new GLP-1 research is intriguing but preliminary [4]. Its real-world cautions, including digestive effects and drug interactions, make a conversation with your healthcare professional the right first step [7][8].
This information is for educational purposes only and is not medical advice. Talk with your healthcare professional before starting any new supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
References
- Blais JE, Huang X, Zhao JV. Overall and sex-specific effect of berberine for the treatment of dyslipidemia in adults: a systematic review and meta-analysis of randomized placebo-controlled trials. Drugs. 2023;83(5):403-427. https://pubmed.ncbi.nlm.nih.gov/36941490/
- Lan J, Zhao Y, Dong F, et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol. 2015;161:69-81. https://pubmed.ncbi.nlm.nih.gov/25498346/
- Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004;10(12):1344-1351. https://pubmed.ncbi.nlm.nih.gov/15531889/
- Sherman A. Catching up with metabolic health supplements: a roundup of the latest science. NutraIngredients. October 9, 2026. https://www.nutraingredients.com/Article/2026/10/09/catching-up-with-metabolic-health-supplement-science/
- Elahi Vahed I, Shahir-Roudi E, Nojumi S, et al. The effect of berberine on obesity indices: a systematic review and meta-analysis. Int J Obes (Lond). 2026;50(1):53-73. https://pubmed.ncbi.nlm.nih.gov/41310257/
- Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717. https://pmc.ncbi.nlm.nih.gov/articles/PMC2410097/
- Guo Y, Chen Y, Tan ZR, et al. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012;68(2):213-217. https://pmc.ncbi.nlm.nih.gov/articles/PMC4898966/
- National Center for Complementary and Integrative Health. Goldenseal. https://www.nccih.nih.gov/health/goldenseal